Reprogramming immunosuppressive myeloid cells by activated T cells promotes the response to anti-PD-1 therapy in colorectal cancer.
- Resource Type
- Article
- Source
- Signal Transduction & Targeted Therapy; 1/8/2021, Vol. 6 Issue 1, p1-14, 14p
- Subject
- Language
- ISSN
- 20959907